课题基金 / 基金详情

项目摘要

项目成果

JOEL K. ELMQUIST的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract The endocannabinoid system, consisting of the CB1R and lipid derived endogenous cannabinoid molecules, has been shown to significantly contribute to the development of diabetes and obesity. Although CB1R inverse agonists are effective at improving insulin sensitivity and protecting against diet induced obesity, these drugs have severe side effects associated with the widespread distribution of CB1Rs in the CNS and the periphery. The goal of this application is to investigate the role of CB1Rs in the SF1 neurons of the ventromedial hypothalamus to regulate energy homeostasis. We will also examine if this subset of neurons is responsible for the metabolic improvements associated with CB1R inverse agonists. We anticipate the results from our investigation will provide novel insight to the development of effective therapies to combat metabolic disease while circumventing potential side effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot and Feasibility Program
  • 批准号:
    10657791
  • 项目类别:
  • 资助金额:
    $20.5万
  • 财政年份:
    2022
  • 负责人:
    JOEL K. ELMQUIST
  • 依托单位:
Pilot and Feasibility Program
  • 批准号:
    10512737
  • 项目类别:
  • 资助金额:
    $20.5万
  • 财政年份:
    2022
  • 负责人:
    JOEL K. ELMQUIST
  • 依托单位:
Leptin Reduction as a Potent Mitigative Strategy for the Treatment of PASC
  • 批准号:
    10554019
  • 项目类别:
  • 资助金额:
    $79.16万
  • 财政年份:
    2021
  • 负责人:
    JOEL K. ELMQUIST
  • 依托单位:
Metabolic Benefits of Leptin Reduction
  • 批准号:
    10621237
  • 项目类别:
  • 资助金额:
    $67.08万
  • 财政年份:
    2021
  • 负责人:
    JOEL K. ELMQUIST
  • 依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: